Blue Cross: national goal to reduce opioids filled at the pharmacy by 30% compared to the opioid prescription peak in 2012

Anthem reduces prescribed opioid use among its members by 15%

http://www.mainebiz.biz/article/20170824/NEWS01/170829974/anthem-reduces-prescribed-opioid-use-among-its-members-by-15%89

South Portland-based Anthem Blue Cross and Blue Shield in Maine reported Wednesday that opioid prescriptions for its individual and employer-sponsored members dropped by 15% in the past year.

Anthem stated in its news release that the primary goal of the quantity limits was to prevent inadvertent addiction and opioid use disorder and to ensure clinically appropriate use consistent with Centers for Disease Control guidelines.

It added that these Maine initiatives contributed significantly to its parent company meeting a national goal to reduce opioids filled at the pharmacy by 30% compared to the opioid prescription peak in 2012.

“This misuse of opioids continues to be a serious issue here in Maine and we are committed to making a significant difference to our members,” said Dan Corcoran, president of Anthem Blue Cross and Blue Shield. “We believe these changes in pharmacy policy, in addition to a broad set of strategies addressing the opioid epidemic, will help prevent, deter and more effectively treat opioid use disorder among our members.”

Last year Maine experienced 376 overdose deaths, the majority of them from opioids.

The pharmacy policy changes are part of Anthem Blue Cross and Blue Shield’s holistic approach to prevention, deterrence and treatment to reduce the impact of this epidemic. To help ensure members have access to comprehensive evidence-based care, Anthem also is committed to helping its affiliated health plans double the number of members who receive behavioral health services as part of medication-assisted therapy, drug and talk therapy, for opioid use disorder by 2019.

 Nationally about 5% of the 4.5 BILLION prescriptions filled annually are for opiates.  Who believes that upwards of 30% of those prescriptions are NOT MEDICALLY NECESSARY… Apparently Anthem/Blue Cross has established a 30% goal of opiate reduced prescribing will save them a “ton of money” that they can add to their bottom line… Their responsibility to cover medically necessary therapy – as required by the beneficiary’s policy/contract – is of little importance and their ability to practice with out a license is being CONDONED or IGNORED by all the 50 states’ medical licensing board.

Corporate profits and your health and safety – guess which is more important !

DETAILS: RNs ask for investigation on patient safety concerns at UPHS-Marquette

http://www.upmatters.com/news/local-news/details-rns-ask-for-investigation-on-patient-safety-concerns-at-uphs-marquette/797475382

(Marquette, MI) Today, nurses delivered a new report called “Misplaced Priorities: The Deteriorating Condition of Safe Patient Care at Duke LifePoint Upper Peninsula Health System-Marquette” to the Michigan Department of Health and Human Services Marquette office. The report, delivered by members of the UPHS Marquette RN Staff Council/Michigan Nurses Association (MNA), is the compilation of hundreds of unsafe patient care reports submitted since January 1, 2017.

The 47-page report includes numerous incidents of unsafe patient care due to short staffing of nurses: http://www.supportUPnurses.org/uploads/7/7/1/1/7711851/08.24.17_final_ado_report.pdf

•    111 reports of one or more IVs running dry or medicines being given late
•    12 reports of one or more patient falls in a shift
     (including four in one day in one unit)
•    259 times one or more nurses went with no breaks, lunches, or were
     mandated to work overtime, which can be dangerous to patients (up to 16
     hour shifts)

“The report we are submitting to the Michigan Department of Health and Human Services today shows that over eight months, reports of unsafe patient care due to nurse short staffing were happening over and over and over again. This is Duke LifePoint’s response to the forms nurses submitted—if we don’t acknowledge the problem, it doesn’t exist,” said Tammy Sustarich, an ICU RN. “Nurses know there’s a problem with unsafe staffing at UPHS Marquette and we are prepared to fight until something is done about it.”

Duke LifePoint and Marquette nurses have been in contract negotiations since April 2017. The contract extension that was negotiated in late May lapsed on July 28 after management failed to address staffing concerns. The nurses are currently working without a contract.

“My life and the life of my patients right now is – what if? What if – today brings more patients than we can handle and things go south in a bad way? What if – today another nurse quits in disgust and we continue to do more with even less than we have now? Or, what if – today Duke LifePoint gets serious about providing safe patient care and puts patients before profits?” said Maradie Milkey, a Labor and Delivery RN in the Family Birth Center.

The nurses have repeatedly asked the management at UPHS Marquette to consider their proposals to address the unsafe staffing conditions. Management has responded by rejecting all of the nurses’ proposals twice. In addition to submitting the report, the nurses announced they will be taking a vote next week to authorize the UPHS Marquette RN Staff Council/MNA negotiating team to call a strike if they feel it is warranted.

“I am disappointed and frustrated that it has come to this,” said Scott Balko, president of the UPHS Marquette RN Staff Council/MNA. “We are seeing a crisis situation unfolding every day in our workplace and our patients are at risk. We have tried reporting it internally and have been ignored. Our patients come first. If it takes reporting UPHS Marquette to the Michigan Department of Health and Human Services to bring safer patient care to our community, then that’s what we’ll do. We can’t count on Duke LifePoint to prioritize safe patient care.”

A summary of the report can be found at supportUPnurses.org.

A request for a statement from UPHS-Marquette has been made by Local 3 News but has not yet been received.

FDA Issues Warnings About Contaminated Medicine

FDA Issues Warnings About Contaminated Medicine

http://www.digitaljournal.com/pr/3463348

Walk into any pharmacy or big box retail store and you’ll see hundreds of over-the-counter medications. As a consumer, it’s great to have choices. In some cases, however, the sheer variety of products is overwhelming. Which ones are best? More importantly, which ones are safe?

Because we live in a country with rigorous safety rules, most people don’t worry about whether a bottle of cold medication or cough syrup is potentially harmful. Unfortunately, sometimes unsafe products make it past quality control standards and onto store shelves.

In August 2017, the Food and Drug Administration (FDA) issued a widespread recall for several different brands of liquid drugs and dietary supplements due to a possible bacteria contamination risk. The recall is extensive — to find out if you have any of the affected drugs in your home, be sure to take a look at the FDA’s recall list.

What the Recall Says

The FDA is warning consumers not to use any “liquid drug or dietary supplement products” made by PharmaTech LLC. The company, which is based in Davie, Florida, labels its products under a variety of names, including Rugby Laboratories, Major Pharmaceuticals, and Leader Brands. The drug manufacturer makes products ranging from stool softeners and dietary supplements to vitamin D drops and medicines for infants and children.

PharmaTech products have been linked to a multistate breakout of an aggressive and potentially deadly bacteria. Currently, the FDA has not reported any deaths associated with the outbreak.

Federal authorities warn that products made by PharmaTech could contain a bacteria called Burkholderia cepacia (B. cepacia), which is known to cause serious respiratory infections. The bacteria are especially harmful to at-risk populations, including the elderly, chronically ill, and infants. B. Cepacia can also cause serious infections in people with lung illnesses, such as cystic fibrosis.

The FDA has instructed consumers who own any of the products covered in the recall to stop using them and to contact the pharmacy or store where they purchased the products to receive a full refund. It’s especially important for parents to take a close look at all drug labels they have in their home. Because newborn babies don’t have a fully developed immune system, they are particularly vulnerable to infections caused by B. cepacia and other bacteria.

Philadelphia Personal Injury Lawyer Discusses Drug Manufacturer Negligence

Philadelphia personal injury lawyer Rand Spear explains, “Consumers rely on medication to make them feel better. The last thing you expect when you purchase over-the-counter drugs is for the medication to make you worse — or possibly land you in the hospital with a life-threatening bacterial infection. If you have any medication produced by PharmaTech in your home, be sure to check it against the FDA’s list of affected drugs covered by the B. cepacia recall.”

Contact a Philadelphia Personal Injury Lawyer Today

If you or a loved one has been injured by a defective or contaminated drug or dietary supplement, protect your rights by speaking to an experienced personal injury lawyer as soon as possible. Call Philadelphia and New Jersey personal injury lawyer Rand Spear today at 877-GET-RAND.

Sources:

Special Guest Speaker Monday Aug 28th 8:00 PM EDT

Dr. Rodger Murphree will be joining us on Monday Aug 28th as a special guest speaker. Dr. Murphree specializes in fibromyalgia, chronic fatigue syndrome, cardiovascular disease, mood disorders, and other difficult-to-treat illnesses. He has five books on these subjects available. Please join us for an evening that promises to be interesting and informative.

https://livesupportgroup.com/join-us/

www.livesupportgroup.com/join-us/

CDC Prescribing Guidelines: Federal Review is Biased and Inconsistent

CDC Prescribing Guidelines: Federal Review is Biased and Inconsistent

https://www.painweek.org/news_posts/cdc-prescribing-guidelines-federal-review-is-biased-and-inconsistent.html

Study Finds Problems in Review Process Used to Justify Recommendations

The 2016 CDC guidelines on opioid prescribing have been faulted in some quarters for a lack of scientific basis, and an article earlier this week discusses a recent study of the federal review process used in their development. Led by past PAINWeek faculty member Daniel Carr, MD, MA, professor of public health and community medicine and program director of pain, research education and policy at Tufts University School of Medicine, the study concluded that the federal review used differing standards for studies of opioid efficacy compared to studies of other treatments including anticonvulsant, antidepressant, nonsteroidal anti-inflammatory drugs (NSAIDs) and behavioral therapies. This led to a biased assessment of the safety and efficacy of long-term opioid therapy compared to other treatment options, according to the authors.

Commenting on the study conclusions, PAINWeek faculty member Jeffrey Fudin, PharmD, co-editor of the Opioids, Substance Abuse and Addictions section of Pain Medicine agreed, saying, “There’s not good evidence for any long-term analgesic drugs, really, for extended periods of time… in 2015, we saw the same number of deaths from prescription NSAIDs that we saw from prescription opioids, and that’s just from gastrointestinal bleeds without consideration to iatrogenic kidney failure and heart disease. People are just selecting what they want to select and using sensationalizing opioid deaths.” There are also problems with the inclusion in the CDC guidelines of morphine equivalent daily dose (MEDD) cited by both Dr. Carr and Dr. Fudin. At the core is the need for more and better education for primary care, according to Dr. Fudin. “We really need to foster safer use of these drugs,” he said. “Somebody needs to require that physicians become highly educated in pain management. That’s the bottom line.”

At PAINWeek 2017, convening September 5-9 in Las Vegas, frontline practitioners can select from over 120 hours of accredited education in pain management. Great registration deals are still available, and can be accessed at www.painweek.org.

Read more about the study with commentary from opposing perspectives.

The journal abstract may be read here.

ACLU trying to “protect” 800 K undocumented/illegal aliens – chronic painers – NOT SO MUCH ?

 

I got awful news last night and I’ve had a pit in my stomach all day. Rumors abound now that Trump is not only seriously considering ending the DACA ( Deferred Action for Childhood Arrivals  https://en.wikipedia.org/wiki/Deferred_Action_for_Childhood_Arrivals  ) program, but that he might do it as soon as today.

This is beyond devastating. The human impact of 800,000 young people losing their legal status in this country is beyond heartbreaking; it is cruel. Every one of them, like the ones we work with every day, would lose their work authorization and be at risk for deportation.

But we’re not done fighting. Please join us.

Today we’re asking you to call your senators and ask them to co-sponsor the Dream Act.

The bipartisan Dream Act would protect DACA-recipients by providing qualified undocumented immigrants who came to the U.S. before the age of 18 a pathway to citizenship. To be eligible, individuals must graduate from high school or pass the GED and either attend college or enlist in the military.

For me, this is personal.

I was previously undocumented and my sister is a current DACA-recipient. She graduated from college last year and is pursuing her dreams in DC. I don’t know what will happen to her if she loses her status, but I’m going to fight for her and the nearly 800,000 young people just like her with all my means.

My sister and I came to this country as children. It is the only place we call home, and we’re fighting beside every ACLU supporter for the inclusive America we believe in.

I will keep you posted with new updates. Thank you for your support.

Lorella Praeli
Director of Immigration Policy and Campaigns, ACLU

I don’t know how many chronic pain pts I have read where they have contacted the ACLU about defending the discrimination against the chronic pain community – some 100 + million… and each request has got REBUFFED…

It would appear the it is CRUEL to deport illegal immigrants but is perfectly acceptable to cause chronic pain pts to be denied their medically necessary medications and cause them to be confined to house, chair, bed ?

Top Massachusetts Court Rules Former Employee Can Sue Employer for Handicap Discrimination After Being Fired for Medical Marijuana Use

Top Massachusetts Court Rules Former Employee Can Sue Employer for Handicap Discrimination After Being Fired for Medical Marijuana Use

www.biggerlawfirm.com/top-massachusetts-court-rules-former-employee-can-sue-employer-for-handicap-discrimination-after-being-fired-for-medical-marijuana-use/

The Massachusetts Superior Court ruled that a woman who was fired for testing positive for marijuana usage can sue her employer for handicap discrimination. Christina Barbuto, who had a doctor’s prescription for medical marijuana, which is legal in Massachusetts, was fired on her first day of work for testing positive for the drug.

Barbuto alleged that she informed Advantage Sales and Marketing during interviews that she uses cannabis several nights a week to treat low appetite, a symptom of her Crohn’s disease. She explained that she followed her doctor’s orders to consume a low dosage before meals, but never consumed cannabis before or during work. She claims the hiring manager told her it would not be a problem. However, Barbuto was fired after failing the required pre-hire drug test.

In response, Barbuto filed a lawsuit against her employer, alleging handicap discrimination. The court ruled against the company, which alleged that she could not sue them for discrimination because marijuana possession remains illegal under federal law. However, Massachusetts Chief Justice Ralph Grant ruled that if a certified doctor determines that marijuana is the best treatment for an employee’s medical condition, an exception to the employer’s drug policy is a reasonable accommodation to make for that employee.

“Under federal law (and many state laws), an employer must provide a reasonable accommodation for any disabled employee as long as the accommodation does not present an undue hardship,” said San Francisco employment attorney Jason Erlich.

According to Justice Grant, the fact that marijuana possession is federally unlawful does not make this exception “per se an unreasonable accommodation.” Justice Grant said Massachusetts recognizes medical marijuana as the same as any other prescription drug, and anti-discrimination laws require companies to create acceptable accommodations for medical marijuana patients.

“By summarily terminating her employment after she tested positive for marijuana, the employer failed to engage in an interactive process with her and failed to discuss whether other equally effective medical alternatives might exist which did not conflict with the company’s drug policy,” Erlich said.

According to Barbuto’s attorneys, her win could set a precedent for employers and employees in Massachusetts, as well as other states where medical marijuana is legal.

Marijuana Use: Federal Law vs. State Law
States that legalized medical marijuana

One issue raised by this case is the relationship between state and federal law on marijuana policy. Marijuana remains illegal under federal law as a schedule one drug, but several states have their own laws regarding marijuana use and distribution.

California was the first state to legalize medical marijuana in 1996 after the California medical community acknowledged that cannabis contains medical benefits that can treat many types of symptoms. Now, 29 states participate in the medical marijuana program, and 8 states and Washington D.C. have legalized recreational marijuana.

However, the way employers implement marijuana policy faces challenges and confusion as the relationship between state and federal laws are often contradictory. “These challenges and confusions exist due to the fact that marijuana remains completely illegal under federal law because it is a schedule one substance (ironically defined as drugs with no commonly accepted medical use with addictive potential). This means, based on federal law, no employee may legally use, possess or sell marijuana. On the other hand, depending on the state, marijuana is either highly regulated but legal for recreational use, or highly regulated but legal for medical use,” said Michigan criminal defense attorney Patrick Barone.

“Marijuana use, distribution and sale has been illegal under the federal government since the early 1970s,” said New Jersey attorney Daniel T. McKillop, who leads a team of attorneys assisting clients operating in the legal cannabis industry. “However, in 2013 former Deputy Attorney General James M. Cole issued a memorandum indicating that in states with robust marijuana regulatory programs that do not interfere with federal enforcement priorities, the Department of Justice may decline to dedicate federal resources to enforcing the prohibition.”

According to McKillop, the Massachusetts ruling stands as a groundbreaking decision that could set a precedent for how similar cases involving employees using medical marijuana outside of work will be handled in court. However, cases like Barbuto’s will continue to arise as state and federal marijuana laws evolve.

As of March 31, 2017, 19 more states have bills pending that would legalize adult-use marijuana. Even on the federal level, lawmakers are trending toward opening up avenues for the decriminalization of the drug. On August 1, Sen. Cory Booker introduced legislation that would remove marijuana from the federal Controlled Substances Act, allowing states to set their own policies.

But until a marijuana rescheduling occurs at the federal level, private marijuana usage will continue to be a contentious and evolving issue for employers and private citizens alike. “This is still a very fluid area of employment law, and employers need to consult with a knowledgeable attorney to avoid litigation issues and stay abreast of state and federal law while implementing employment policies,” McKillop said.

Another reason why pts should record office visits with prescribers ?

Study: Patients’ hearing loss may mean poorer medical care

https://www.upi.com/Health_News/2017/08/24/Study-Patients-hearing-loss-may-mean-poorer-medical-care/7971503593347/

THURSDAY, Aug. 24, 2017 — Many seniors may not hear everything their doctors tell them, new research suggests, and that could raise the risk of medical errors.

“In our study of 100 patients 60 and older, 43 reported mishearing a doctor or nurse in an inpatient or community health care setting, lending vulnerability to unintended error,” said researcher Simon Smith, from the University College Cork School of Medicine, in Ireland.

Earlier research has found that improved communication between doctors, nurses and families could prevent 36 percent of medical errors, Smith added.

The problem is not just a matter of doctors speaking louder. “The ability to separate speech from background noise is more intricate than volume alone,” he explained.

Often hearing tests don’t capture the complexity of how patients process medical information, and hearing aids may not be the answer, Smith said.

The process that leads to miscommunication that starts with hearing loss needs more study to help patients better understand what’s being told to them and to help find ways for doctors to better communicate, he said.

The report was published online Aug. 24 in the journal JAMA Otolaryngology–Head & Neck Surgery.

According to Dr. Darius Kohan, director of otology/neurotology at Lenox Hill Hospital in New York City, “This article brings into focus a major problem that patients and families and health care providers share in common: the flow of communication among the parties involved.”

After 60, a significant number of men and women start to have hearing problems, which can hamper communication, he said.

“This is even more of a problem in the medical field,” Kohan pointed out.

“Often in the medical care setting there is background noise impeding hearing, the content is often technical and unfamiliar to patients and families, and the setting is stressful on patients who may already be in distress due to their medical condition,” he explained.

In addition, doctors and other health care providers may also suffer from hearing loss and not always hear patients’ concerns.

Part of the solution could be quiet rooms in hospitals and clinics “where the flow of medical information between health care providers and patients and families can occur in private,” Kohan suggested.

“The hard-of-hearing must have means available to facilitate hearing and communication among clinicians and patients,” he said.

“Although this study is on a very small patient population, one can extrapolate their results to the rest of the medical community,” he added.

In the study, Smith and his colleagues found that 57 of the 100 seniors had some degree of hearing loss and 26 used a hearing aid. Moreover, 43 participants said they had misheard a doctor, nurse or both in a primary care office or hospital.

The main types of mishearing included misunderstanding what was said to them, not correctly hearing a doctor’s diagnosis or advice, and general breakdown in doctor-to-patient communication, Smith said.

One geriatric specialist said loss of hearing among older adults is a problem she encounters every day.

“It’s important that we assess hearing and treat hearing loss, because hearing loss also affects our memory and our brain stimulation. So when we lose that sensation of hearing we also lose information access and that can cause slowing of our mental function,” said Dr. Maria Torroella Carney. She is chief of the division of geriatric and palliative medicine at Northwell Health, in New Hyde Park, N.Y.

Many people have hearing loss, but don’t get a hearing aid. Hearing aids are often not covered by insurance, Carney noted.

“Hearing aids cost thousands of dollars, so patients don’t pursue it until absolutely necessary,” she said.

With some patients, Carney uses a hearing amplifier, which is a simple device that can help some patients hear better by increasing the volume of sound directly in their ear.

“That’s a tool we use regularly with our patients,” she said. “It’s remarkable when we bypass the hearing deficit. You don’t really appreciate how much they were missing until you use a device like that. It helps [you] communicate much better, especially when you have to communicate important information.”

For example, Carney recently used the amplifier with a patient who was then able to describe pain in detail, when before the patient did not understand the questions she was asking.

The device also helps patients understand medication instructions, she said. “If patients aren’t hearing everything, they don’t understand and they are not going to ask clarifying questions,” she said.

Carney added that hearing loss can make patients feel isolated and affect their quality of life.

It’s important to test older patients’ hearing and find the best ways to help, because restoring hearing can keep patients mentally alert, she said.

Christie strikes tougher tone on opiod prosecutions. Will it get Trump to act on opioids?

Christie strikes tougher tone on opiod prosecutions. Will it get Trump to act on opioids?

http://www.nj.com/politics/index.ssf/2017/08/christie_sounds_a_lot_more_like_jeff_sessions_thes.html

 

NEWARK —  Gov. Chris Christie on Thursday evening again called for President Donald Trump to formally declare a national emergency in response to a plague of opioid overdoses that last year claimed more American lives than did the peak of the HIV/AIDS epidemic.

But as he did, the governor also publicly embraced the Justice’s Department’s new harder line on drug prosecutions to encourage a president whose administration has been inconsistent and hesitant in its response to the overdose crisis.

“I hope that when we get new leadership at the U.S. attorney’s office, that we’ll return to a time when we’re once again aggressive about drug enforcement as part of what needs to be done,” said Christie, who spent seven years as a U.S. attorney for New Jersey.

Laxness in interdiction, Christie argued Thursday, was helping fuel addiction.

“People who are profiting from spreading death throughout our neighborhoods and our communities need to held accountable and need to be put in jail for that.”

That jibes with U.S. Attorney General Jeff Sessions new policy of seeking drug convictions that “carry the most substantial guidelines sentence, including mandatory minimum sentences.”

But the governor made his remarks at a showcase of artwork from opioid addicts in recovery, and the crowd of 100 applauded cautiously at this new, harder-line rhetoric.

Christie has devoted his final year in office to addressing opioid addiction, and in March, Trump appointed him chair of presidential commission tasked with determining the federal response to the opioid crisis.

However, the president has vacillated on whether to accept the findings of the commission’s interim report.

Two weeks ago, Christie and his five member presidential commission unanimously argued for the declaration of a national emergency by the president, noting that 142 Americans die of drug overdoses daily, mostly from opioids.

What Christie said about Trump’s neo-Nazi comparisons

At first, Trump’s White House seemed to dismiss the national emergency declaration recommendation.

“We believe at this point that the resources that we need or focus that we need to bring to bear to the opioid crisis can be addressed without the declaration of emergency,” said Health and Human Services Secretary Tom Price on August 8.

But two days later, when Trump was asked by a reporter why the loss of as many American lives as were claimed by the 9/11 attacks every three weeks was not a national emergency, the president reversed himself.

“The opioid crisis is an emergency and I’m saying right now it’s an emergency. It’s a national emergency,” Trump said on August 10. “We’re going to draw it up and we’re going to make it a national emergency.”

Two weeks later, there’s been no formal emergency declaration by Trump.

On Thursday, a White House spokesman told CNN that the delay was because of “a legal review” and said that “we are declaring one but we are considering which option to use to declare one.”

A national emergency declaration made under the Stafford Act would provides access to resources and funding typically used by FEMA after natural disasters like Superstorm Sandy. Declaring one under the Public Health Services Act would give the Health and Human Services Department broader authority to act.

On Thursday, Christie again pressed his case for the president to make a formal declaration.

“I urged the president to declare a national emergency because this is a national emergency,” said Christie Thursday. “Let us have the kind of response that that loss of life that we had to the loss of life in the World Trade Center, and the Pentagon and Shanksville, Pennsylvania.”

But as he exited the DEA’s second annual opioid-themed art show at Newark’s Gateway Center, the governor declined to answer questions about if he knew why the president had not made a formal emergency declaration.

FEDERAL COURT: DEA can go on “fishing exposition” in state’s PMP WITHOUT WARRANT

Utah to Obey Order for DEA Drug Database Search

www.hightimes.com/news/utah-to-obey-order-for-dea-drug-database-search/

SALT LAKE CITY (AP) — Utah will obey a court order to let the U.S. Drug Enforcement Administration search a prescription-drug database without a warrant, despite a state law designed to protect patient privacy.

The state disagrees with the ruling that found people can’t expect privacy in the highly regulated prescription-drug industry, but state attorneys have decided not to appeal after reviewing similar cases, said Utah Attorney General’s Office spokesman Dan Burton in a statement Monday.

A federal appeals court also sided with the DEA in a case involving subpoenas of Oregon’s prescription-drug database.

All states maintain similar databases to help doctors and pharmacists prevent overprescribing amid a national opioid-drug epidemic. The databases hold records of medications like the anti-anxiety drug Xanax and sleep aid Ambien as well as opioid painkillers.

Utah is among a minority of states requiring police to get a warrant before they search the database. Utah state law enforcement will still have to follow the law, Burton said.

American Civil Liberties Union of Utah attorney John Mejia said he’s disappointed in Utah’s decision not to appeal the federal court judge’s ruling.

The DEA fought to be exempt from the law, saying the searches are an important tool in early investigations. The agency sued after agents asked to search the database to find out whether a medical provider was prescribing drugs to members of a criminal organization with ties overseas.

Officials refused to allow the search without a warrant, following a law that passed after two firefighters were wrongly charged with prescription-drug fraud following a wide-ranging search of the database in an ambulance drug theft investigation.

The firefighters were not linked to the thefts, but their relatively high number of prescriptions raised suspicion. The charges were later dropped after they showed all the drugs were properly prescribed, but still put their careers and personal lives at risk, they said.

The firefighters union joined the case to keep the DEA out of the database, as did an LGBT group. Equality Utah argued that the searches violate the privacy of transgender people whose hormone medications are recorded in the database.

But U.S. District Judge David Nuffer decided last month that database queries don’t violate laws against unreasonable search and seizure because the prescription drugs are already tightly controlled.

“Prescription drugs are a highly regulated industry in which patients and doctors do not have a reasonable expectation of privacy,” he wrote in the ruling handed down last month.